127 related articles for article (PubMed ID: 38316186)
21. Effects of dialysis membrane on intradialytic vancomycin administration.
Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
[TBL] [Abstract][Full Text] [Related]
22. Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients.
Tsurumi-Ikeya Y; Tamura K; Azuma K; Mitsuhashi H; Wakui H; Nakazawa I; Sugano T; Mochida Y; Ebina T; Hirawa N; Toya Y; Uchino K; Umemura S
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1058-65. PubMed ID: 20203302
[TBL] [Abstract][Full Text] [Related]
23. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
24. Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease.
Tsumura M; Kinouchi T; Ono S; Nakajima T; Komoda T
Clin Chim Acta; 2001 Dec; 314(1-2):27-37. PubMed ID: 11718676
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
[TBL] [Abstract][Full Text] [Related]
26. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
[TBL] [Abstract][Full Text] [Related]
27. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: change in prostacyclin and effect on ischemic symptoms.
Mii S; Mori A; Sakata H; Nakayama M; Tsuruta H
Angiology; 1998 Mar; 49(3):175-80. PubMed ID: 9523539
[TBL] [Abstract][Full Text] [Related]
28. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
Kobayashi J; Katsube S; Shimoda M; Furuhashi K; Kitano S; Masuda M; Maruyama T; Shinomiya M
Clin Chim Acta; 2002 Jul; 321(1-2):107-12. PubMed ID: 12031599
[TBL] [Abstract][Full Text] [Related]
29. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
Bambauer R; Schiel R; Latza R
Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
[TBL] [Abstract][Full Text] [Related]
30. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E
Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791
[TBL] [Abstract][Full Text] [Related]
31. LDL-apheresis dramatically improves generalized calciphylaxis in a patient undergoing hemodialysis.
Iwagami M; Mochida Y; Ishioka K; Oka M; Moriya H; Ohtake T; Hidaka S; Kobayashi S
Clin Nephrol; 2014 Mar; 81(3):198-202. PubMed ID: 23036228
[TBL] [Abstract][Full Text] [Related]
32. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment using percutaneous transluminal angioplasty and low-density lipoprotein apheresis in a patient with peripheral arterial disease and a history of chronic hemodialysis.
Nishimura H; Enokida H; Tsuruta M; Yoshino Y; Yamada Y; Sugita S; Hayashi S; Arata K; Hayami H; Nishiyama K; Nakagawa M
J Clin Apher; 2013 Aug; 28(4):330-4. PubMed ID: 23450792
[TBL] [Abstract][Full Text] [Related]
34. Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy.
Koshi-Ito E; Koike K; Tanaka A; Watanabe Y; Kamegai N; Shimogushi H; Shinjo H; Otsuka Y; Inaguma D; Takeda A
Ther Apher Dial; 2019 Dec; 23(6):575-583. PubMed ID: 30993827
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.
Moriarty PM; Gibson CA
Curr Atheroscler Rep; 2001 Mar; 3(2):156-62. PubMed ID: 11177660
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Evolocumab vs low-density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01).
Torres E; Goicoechea M; Hernández A; Rodríguez Ferrero ML; García A; Macías N; Anaya F
J Clin Apher; 2020 Jan; 35(1):9-17. PubMed ID: 31663632
[TBL] [Abstract][Full Text] [Related]
37. [Monitoring of vancomycin plasma levels in patients undergoing hemodialysis].
Ruano R; Martín-Reyes G; Muñoz I; Pizarro JL; Gallego C; Moreno MV; Ruiz J; Franquelo R; Ramos B; Fernández J
Farm Hosp; 2005; 29(6):354-8. PubMed ID: 16433565
[TBL] [Abstract][Full Text] [Related]
38. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
39. LDL apheresis in atherosclerotic disease with hyperlipidemia.
Naganuma S; Agishi T; Ota K
ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
[TBL] [Abstract][Full Text] [Related]
40. Low-Density Lipoprotein Apheresis Ameliorates Renal Prognosis of Cholesterol Crystal Embolism.
Ishiyama K; Sato T; Taguma Y
Ther Apher Dial; 2015 Aug; 19(4):355-60. PubMed ID: 26386224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
